AVE 33.3% 0.2¢ avecho biotechnology limited

what's next for 2012???, page-30

  1. 2,006 Posts.
    Thought I'd throw this into the what's next for 2012 mix.

    To begin with: Completion of Phase 1 Trials.

    Was open to recruitment as of 11/1/12 (see page 7),
    and registered retrospectively at that time.

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.